Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
SynAct
-
search results
If you're not happy with the results, please do another search
SynAct Pharma’s Chairman: ”We are confident we have the right strategy”
2 October, 2024
SynAct Pharma moves forward with filing process
4 July, 2024
SynAct Pharma’s CEO provides an update
2 May, 2024
Synact focuses on pushing forward rheumatoid arthritis project
2 April, 2024
Synact’s new CEO: “I’m hitting the ground running”
22 March, 2024
Deep dive into SynAct Pharma’s new strategy
8 February, 2024
Major shareholders in SynAct Pharma request board change
29 January, 2024
SynAct Pharma raises 60,5 MSEK through a directed share issue
12 October, 2023
Positive subgroup data in SynAct Pharmas’s EXPAND study
19 September, 2023
SynAct Pharma’s CEO comments on EXPAND data
7 September, 2023
SynAct Pharma’s CEO comments on the recent progress
21 July, 2023
The BioStock Life Science Spring Summit 2023 goes live today
30 May, 2023
Highlights from SynAct Pharma’s Capital Markets Day
17 May, 2023
SynAct completes patient recruitment ahead of schedule
25 April, 2023
Interview with Synact Pharma about the changes in the company
3 April, 2023
SynAct Pharma announces change in management
3 April, 2023
Progress for SynAct Pharma in 2022 – more milestones ahead
24 February, 2023
SynAct Pharma’s acquisition of TXP Pharma concluded
19 January, 2023
SynAct Pharma’s CSO comments approved IND and Q3
4 November, 2022
GSK terminates RA project
28 October, 2022
October 12 – World Arthritis Day
12 October, 2022
SynAct submits IND and recruits first patient
10 October, 2022
SynAct comments on the revision of nephrology study
16 September, 2022
SynAct Pharma summarises busy second quarter
5 August, 2022
SynAct Pharma ready for phase IIb and uplisting
1 July, 2022
Watch day 2 of the BioStock Life Science Spring Summit
9 June, 2022
The BioStock Life Science Spring Summit starts now
8 June, 2022
RA patients in great need of new treatment options
5 May, 2022
BioStock Studio: SynAct Pharma’s CEO on the rights issue and partnering...
6 April, 2022
BioStock Life Science Spring Summit, June 8-9, 2022
26 March, 2022
SynAct Pharma well positioned for an eventful 2022
14 February, 2022
BioStock Studio: SynAct Pharma comments on the promising study results in...
3 December, 2021
SynAct Pharma’s CSO and CMO comment on clinical development
11 November, 2021
Synact Pharma on expansion into Covid-19
5 July, 2021
SynAct Pharma sees potential in several viral diseases
22 September, 2020
SynAct comments on positive Phase II data
6 May, 2020
